title: Allo-SCT for hematological malignancies in the setting of HIV.
authors.forename: M N
authors.initials: MN
authors.lastname: Polizzotto
authors.forename: M
authors.initials: M
authors.lastname: Skinner
authors.forename: M F
authors.initials: MF
authors.lastname: Cole-Sinclair
authors.forename: S S
authors.initials: SS
authors.lastname: Opat
authors.forename: A
authors.initials: A
authors.lastname: Spencer
authors.forename: S
authors.initials: S
authors.lastname: Avery
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000821:virology; D019337:Hematologic Neoplasms / Q000150:complications* / Q000628:therapy*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000628:therapy; D008297:Male; D036102:Peripheral Blood Stem Cell Transplantation; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000628:therapy; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D055815:Young Adult